We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Information about the EU Regulations and their implementation in Northern Ireland
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Information and guidance on a range of medical devices for users and patients.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
Mental health support and advice facilities for service personnel, reservists, veterans and service families.
Submission dates and how the submissions using the EC decision reliance procedure work.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
The Advisory Group on Military and Emergency Response Medicine (AGMERM) provides specialist advice to the Ministry of Defence on the medical aspects of defence against chemical, biological and radiological threats. AGMERM works with the Ministry of Defence .
How the MHRA makes decisions on what is a medicinal product (borderline products).
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
The way you apply to licence biological products has changed
Marburg virus is a Filovirus which, along with Ebola virus, can cause a severe and often fatal viral haemorrhagic fever (VHF).
Guidance on defining intended purpose for Software as a Medical Device (SaMD), to help SaMD manufacturers in meeting their statutory obligations.
Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).